MediPal Holdings Corporation Share Price Other OTC
Equities
MAHLY
US58502T1079
Pharmaceuticals
Sales 2024 * | 3,527B 22.72B 1,820B | Sales 2025 * | 3,561B 22.95B 1,838B | Capitalization | 519B 3.34B 268B |
---|---|---|---|---|---|
Net income 2024 * | 35.7B 230M 18.42B | Net income 2025 * | 35.68B 230M 18.41B | EV / Sales 2024 * | 0.15 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.15 x |
P/E ratio 2024 * |
14.6
x | P/E ratio 2025 * |
14.8
x | Employees | - |
Yield 2024 * |
2.43% | Yield 2025 * |
2.54% | Free-Float | 84.27% |
Managers | Title | Age | Since |
---|---|---|---|
Shuichi Watanabe
PSD | President | 72 | 31/03/00 |
Midori Ito
CMP | Compliance Officer | - | - |
Takeshi Yanagida
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Shuichi Watanabe
PSD | President | 72 | 31/03/00 |
Toshihide Yoda
BRD | Director/Board Member | 61 | 31/05/10 |
Director/Board Member | 69 | 01/04/77 |
1st Jan change | Capi. | |
---|---|---|
+17.88% | 70.09B | |
-1.07% | 24.01B | |
+8.01% | 8.32B | |
-18.28% | 8.23B | |
+1.96% | 8.08B | |
+4.40% | 4.68B | |
+16.55% | 4.41B | |
-0.70% | 4.12B | |
-2.20% | 3.88B |